Table 3.
Predictive accuracy of atypical antipsychotic adherence patterns
| Atypical adherence group | Other drug adherence group | ACE inhibitor share within atypical group (%) | Biguanides share within atypical group (%) | SSRI Share within atypical group (%) |
|---|---|---|---|---|
| Non-adherent | Non-adherent | 40 | 37 | 51 |
| Gradual discontinuation | 14 | 13 | 15 | |
| Stop–start | 12 | 16 | 9 | |
| Adherent | 34 | 34 | 25 | |
| Gradual discontinuation | Non-adherent | 32 | 35 | 28 |
| Gradual discontinuation | 21 | 17 | 33 | |
| Stop–start | 12 | 15 | 10 | |
| Adherent | 35 | 32 | 30 | |
| Stop–start | Non-adherent | 28 | 28 | 27 |
| Gradual discontinuation | 14 | 15 | 16 | |
| Stop–start | 21 | 24 | 27 | |
| Adherent | 36 | 33 | 30 | |
| Adherent | Non-adherent | 19 | 16 | 17 |
| Gradual discontinuation | 14 | 14 | 14 | |
| Stop–start | 9 | 11 | 7 | |
| Adherent | 59 | 60 | 61 | |
| Accuracy | 44.5 | 44.5 | 49.6 | |
| Difference from random accuracy (25%) | 19.5 | 19.5 | 24.6 | |
| p value | < 0.001 | < 0.001 | < 0.001 | |
Non-adherent PDC < 80%; Adherent PDC ≥ 80%